TORONTO, Nov. 22,
2021 /CNW/ - Dr. Pradip
Banerjee, Chair and Chief Executive Officer, Xybion Digital
Inc. ("Xybion" or the "Company") (TSXV: XYBN) and his team joined
Omar Khafagy, Manager, Corporate
Access, TMX Group, to celebrate the Company's new listing on the
TSX Venture Exchange and to close the market.
Xybion is a global SaaS company that helps enterprise life
sciences organizations accelerate new drug development into
approved medicines that save lives and keep employees safe. They
digitize drug research and development, laboratory testing,
regulatory approvals, and pharmaceutical manufacturing on a single,
unified cloud platform that is cost-effective, ready to deploy, and
easy to use. Xybion has over 160 clients in 25 countries using its
low-code software to accelerate timelines, improve compliance,
expand capacity, minimize operating risks, and reduce expenses
while keeping employees safe. For more information please visit
https://www.xybion.com.
SOURCE TSX Venture Exchange